Perspective Therapeutics, Inc. ( CATX) - Key Metrics
CATX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.67 | -$222.01 | -$171.15 | -$288.81 |
| 2026Q1 | $0 | -$0.35 | -$0.43 | -$0.52 |
| 2025Q4 | $0 | -$0.51 | -$0.33 | -$0.40 |
| 2025Q3 | $0 | -$0.35 | -$0.22 | -$0.25 |
| 2025Q2 | $0 | -$0.30 | -$0.28 | -$0.30 |
CATX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.88 |
| 2026Q1 | 0% | -2.98 |
| 2025Q4 | 0% | -1.35 |
| 2025Q3 | 0% | -2.45 |
| 2025Q2 | 0% | -2.87 |
CATX
Price: $2.66
52 week price:
Earnings Per Share: -1.33 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 284.0 million